Loading...
Loading...
NuVasive, Inc.
NUVA, a medical device company focused on developing minimally
disruptive surgical products and procedures for the spine, is proud
to announce that the very first eXtreme Lateral Interbody Fusion
(XLIF(R)) procedures were performed yesterday and today at two
different hospitals in Japan.
NuVasive has received regulatory Shonin approval for several products
to offer the XLIF surgical technique as a minimally invasive option
for lumbar spine fusion to patients and surgeons in Japan. The
approval furthers the Company's ability to participate in the
Japanese market, adding the XLIF approach to the cervical and
posterior products that were approved for use late last year.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in